PTPRC and myocardial infarction: Additional experiments showed reduced presence of CD45+ (leukocyte common antigen) and CD68+ (macrophage antigen) inflammatory cells in the non-infarct region at 1 week post-MI in the AAV9-WNT11 treated group.